Imaging As an Early Biomarker to Predict Sensitivity to Everolimus for Progressive NF2-related Vestibular Schwannoma.
Journal of Neuro-Oncology（2024）
Key words
Vestibular schwannoma,NF2,Everolimus,Mammalian target of rapamycin (mTOR) inhibitors,Clinical trial,Quantitative imaging biomarkers
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined